Conquering epilepsies & brain disorders with courageous science
Science-driven and patient-focused, our mission is to develop medicines that transform the lives of patients with epilepsies and seizure-related disorders.
Our deep understanding of human genetics and cellular function enables us to translate discoveries into meaningful therapies for epilepsies and seizure-related disorders.
At Ovid, we seek to understand what matters most to individuals with rare diseases and their families. We are committed to address the challenges they face every day.
- Ovid Therapeutics Dosed Healthy Volunteers with OV329 in Phase 1 Trial
- Ovid Therapeutics to Present Data on Its Epilepsy Programs at American Epilepsy Society Annual Meeting (2022)
- Ovid Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
- Ovid Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference